Every post on peptips starts as a question a reader asked us. We keep the queue public so you can see what is coming, push back, and tell us what we are missing. Send us a question and it goes into this list.
The labels say discontinue at least two months before a planned pregnancy, but readers ask us about unplanned ones every week.
Off-label step-down practice is real and rarely written about calmly.
Reduced reward signalling shows up in animal models and small human trials, and readers feel it.
Tirzepatide is one molecule with two FDA approvals. Readers want a calm, cited comparison without the telehealth pitch.
Most muscle-preservation advice online is borrowed from bodybuilding. The trial literature is more specific and more useful.
The pill is real and underdiscussed. The dosing window matters.
Rodent C-cell findings drive the label. We want a calm, cited reading.
The trial data on stopping is now strong enough to be specific about. Most coverage is still vague.
The best questions on this list came from readers. Send us a question and it goes into the queue.